Compare Nucor Corporation (NUE) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nucor Corporation vs Summit Therapeutics Inc — how do they compare? Nucor Corporation trades at $230.8 (market cap $52.55B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Nucor Corporation is far larger — about 5× Summit Therapeutics Inc's market cap, and Nucor Corporation pays a 0.97% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| NUE | SMMT | |
|---|---|---|
Market Cap | $52.55B | $10.48B |
Sector | Basic Materials | Health |
52-Week High | $266.35 | $29.32 |
52-Week Low | $131.78 | $13.05 |
Enterprise Value | $57.19B | $9.90B |
Dividend Yield | 0.97% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
